Biotech
Latest news, analysis, and insights about Biotech.
Why Google DeepMind's Bioresilience Strategy Will Shape the Future of Biotech Regulation
Google DeepMind and Isomorphic Labs have released a joint strategy for biological safety. This framework aims to mitigate the dual-use risks of advanced AI models in drug discovery and genetics.
Why Breakout Ventures Is Defying the Biotech Winter With a New $114M Early-Stage AI Fund
While traditional venture capital flees to clinical-stage safety, Breakout Ventures has closed a $114 million fund. Their bet? AI fundamentally breaks the cost curves of early-stage scientific discovery.
Why Lightspeed Is Backing Former OpenAI Researcher Miles Wang at a $2 Billion Valuation
OpenAI researcher Miles Wang is in talks to spin out a new AI drug discovery startup at a $2 billion valuation. The deal, reportedly led by Lightspeed, signals a massive shift toward verticalized AI in the physical sciences.
OpenAI-Backed Chai Discovery Hits $1.3B Valuation With Foundation Models for Drug Discovery
Chai Discovery just raised $130M at a $1.3 billion valuation, with OpenAI among its backers. The startup is applying foundation model techniques to predict molecular interactions—and it signals a broader AI-biotech convergence.